We are grateful to the Indian Knowledge System (IKS) Division, Ministry of Education (MoE), Government of India, for the financial support provided for this research work and fellowship for SR through project [F.2-23/AICTE/IKS-BGS1/ResearchProject/2022-23/24]
By 2031, CR drugs are forecast to be the top non-GLP-1R obesity drug type, generating $5.43bn, equivalent to 35% of all sales attributed to non-GLP-1R drugs
& Vetreno, R
Frequently Asked Questions Which program costs less, SunLight or Gala GLP-1
Mass Production as Evidence of Intent: If a pharmacy compounds thousands of Semaglutide + B12 doses, it suggests a manufacturing strategy to evade regulations, rather than a response to individual patient needs
Hydrogen atoms were added using pdb2gmx, and the complex was solvated in a cubic TIP3P water box with a 10 buffer